No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
IGC240621P2500
- 1.80
- -0.70-28.00%
15min DelayClose Jun 20 15:58 ET
1.80High1.80Low
1.80Open2.50Pre Close1 Volume4 Open Interest2.50Strike Price180.00Turnover1372.11%IV-74.13%PremiumJun 21, 2024Expiry Date2.10Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9704Delta0.2138Gamma0.19Leverage Ratio-0.0026Theta-0.0001Rho-0.19Eff Leverage0.0000Vega
Intraday
- 5D
- Daily
News
IGC Pharma to Participate in Fireside Chat With Ascendiant Capital Markets
Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
Anson Funds agreed to a $2.25 million settlement with the Securities and Exchange Commission (SEC) over a secret relationship with a short seller affecting two cannabis companies. The SEC found that w
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersViracta Therapeutics (NASDAQ:VIRX) stock increased by 16.8% to $0.68 during Tuesday's pre-market session. The company's market cap stands at $26.7 million. Purple Biotech (NASDAQ:PPBT) stock in
Express News | IGC Pharma Publishes Study In European Society Of Medicine For Impact Of CYP2C9 Genetic Polymorphism On Pharmacokinetics Of Delta 9 Tetrahydrocannabinol
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLiquidia (NASDAQ:LQDA) stock rose 12.7% to $14.5 during Friday's after-market session. The market value of their outstanding shares is at $1.1 billion. Adagene (NASDAQ:ADAG) shares moved upward
Express News | IGC Pharma Announces Patient Enrollment At Neurostudies For Its Phase 2 Trial Of IGC-AD1 In Alzheimer's
Comments
$IGC Pharma(IGC.US$ Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
Benzinga· 3 mins ago
Anson Funds agreed to a $2.25 million settlement with the Securities and Exchange Commission (SEC) over a secret relationship with a short seller affecting two cannabis companies. The SEC found that while Anson Funds disclosed its short position strategy to investors, it did not reveal its collaboratio...
Benzinga· 3 mins ago
Anson Funds agreed to a $2.25 million settlement with the Securities and Exchange Commission (SEC) over a secret relationship with a short seller affecting two cannabis companies. The SEC found that while Anson Funds disclosed its short position strategy to investors, it did not reveal its collaboratio...
1
$IGC Pharma(IGC.US$ IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1! Advancing IGC-AD1 Toward Commercialization as a Treatment for Agitation in Alzheimer's
1
$IGC Pharma(IGC.US$
IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
2
Little AH pop. Here are the levels to watch for continuation.
Larger Image: tradingview.com...
$IGC Pharma(IGC.US$
Larger Image: tradingview.com...
$IGC Pharma(IGC.US$
Read more